ReviewCurrent nutrition reports2026
Aronia Melanocarpa as a Multifunctional Superberry: From Antioxidant Potential to Therapeutic and Nanotechnological Applications.
Review in Current nutrition reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Review ofFoods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewThis review aims to provide an overview of the nutritional composition, bioactive compounds, and health-promoting properties of Aronia melanocarpa, with a particular focus on its antioxidant capacity and potential therapeutic applications in chronic disease prevention and management. RECENT
findingsIn vitro, in vivo, and clinical studies indicate that Aronia melanocarpa exerts potent antioxidant, anti-inflammatory, antidiabetic, cardioprotective, anti-obesity, and anticancer effects, attributed mainly to its rich anthocyanin and procyanidin content. Human intervention trials have shown improved antioxidant status, lipid and glucose metabolism, vascular function, and inflammatory markers. However, some results remain inconclusive due to differences in cultivar, processing, dosage, and individuals. Supporting evidence from animal and cellular models highlights the regulation of NF-κB and AMPK signaling pathways, modulation of gut microbiota, and protective effects against metabolic and age-related disorders. Furthermore, novel applications in nanotechnology demonstrate that Aronia melanocarpa extracts can serve as eco-friendly agents in synthesizing bioactive nanoparticles with antioxidant, antimicrobial, and biomedical potential. Aronia melanocarpa is a promising functional food with strong potential for nutraceutical and therapeutic applications. While experimental evidence supports its health benefits, human clinical data remain insufficient to establish standardized dosage and long-term use recommendations. Future research should focus on well-designed clinical trials, bioavailability optimization, and fully elucidating the role of Aronia melanocarpa in health promotion and disease prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.